Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
If you're taking semaglutide and planning pregnancy, timing matters. Most clinical evidence suggests semaglutide has a half-life of 7 days, meaning your body eliminates half the drug weekly—but reproductive safety planning involves more than just metabolism. This guide breaks down what current research shows and how PlexusDx supports women navigating weight loss and family planning.
Semaglutide Half-Life and Pregnancy Timeline
Semaglutide's half-life of approximately 7 days means the medication begins leaving your system immediately after your last dose. After one week, roughly 50% is gone; after two weeks, about 75% is eliminated; by three to four weeks, trace amounts may remain. Most reproductive endocrinologists recommend stopping semaglutide at least one full cycle (28 days) before attempting conception, though some studies suggest two to three menstrual cycles provide additional safety margin for those who've been on the drug longer than six months.
The key distinction: semaglutide itself clears relatively fast, but your body's response to the medication—including appetite regulation, glucose metabolism, and hormonal adjustments—may take longer to fully normalize. Weight gain during this transition is common and expected. PlexusDx recommends working with both your prescriber and OB-GYN to establish a coordinated discontinuation plan that accounts for your individual treatment duration and metabolic baseline.
How GLP-1 Medications Affect Fertility and Pregnancy
Current evidence from Phase 2 and Phase 3 clinical trials shows no direct evidence that semaglutide impairs ovulation, sperm production, or fertilization rates in humans. Animal reproduction studies did not show fetal harm at doses comparable to human therapeutic levels. However, semaglutide was not extensively studied in pregnant populations, so manufacturers classify it as Pregnancy Category C—meaning animal data is available but human pregnancy data is limited.
Severe rapid weight loss before pregnancy can disrupt ovulation through caloric restriction and hormone imbalance. If you've achieved significant weight loss on semaglutide, the transition off the medication—combined with proper nutrition and realistic expectations about weight regain—helps maintain hormonal stability needed for conception. Inadequate calorie intake during the washout period is a bigger fertility risk than the semaglutide itself. PlexusDx encourages consultation with a reproductive endocrinologist or fertility specialist if you have irregular cycles, a history of polycystic ovary syndrome (PCOS), or concerns about ovulatory function.
Safety Considerations Before, During, and After Pregnancy
Semaglutide crosses the placenta, and no adequate human pregnancy data exists, making it contraindicated (not recommended) during pregnancy. Stopping the medication before conception is standard medical practice supported by manufacturer guidance and reproductive health organizations. Most guidelines suggest discontinuing semaglutide as soon as pregnancy is confirmed if it was not stopped beforehand; no evidence suggests harm from brief fetal exposure, but continuation is not warranted.
Postpartum weight loss while breastfeeding requires special caution. If you plan to breastfeed, discuss with your OB-GYN before restarting semaglutide, as limited data exists on semaglutide transfer into breast milk. Many women choose to delay GLP-1 restart until breastfeeding is complete. PlexusDx supports this conversation with your medical team and can help you resume personalized GLP-1 therapy after pregnancy and postpartum recovery with full medical coordination.
Personalized Fertility Planning with PlexusDx Semaglutide
Pregnancy planning while on GLP-1 therapy is highly individual—influenced by how long you've been treated, your current weight, your metabolic health baseline, and your fertility status. PlexusDx Semaglutide Injection (starting at $149/month) is designed for flexibility: you can pause treatment temporarily, restart after pregnancy recovery, or adjust your approach based on your reproductive timeline. No membership fees or insurance requirements mean you control your treatment schedule without financial penalties.
PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) maps your genetic predispositions across 14 peptide pathways and 49 peptides—including variants affecting GLP1 receptor sensitivity (GLP1R rs6923761) and metabolic set-point (FTO rs9939609). Understanding your genetic profile helps your medical team anticipate how your body may respond during the transition off semaglutide and plan postpartum resumption strategically. All PlexusDx compounds come from licensed 503A compounding pharmacies and are available across all 50 states.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How long after stopping semaglutide can I start trying to get pregnant?
Most reproductive specialists recommend waiting one full menstrual cycle (28 days) after your last semaglutide dose, though two to three cycles is preferred if you've been on the medication long-term. This allows your metabolism and hormone levels to stabilize. PlexusDx recommends coordinating with both your weight loss provider and OB-GYN to set a precise timeline based on your individual history.
Will semaglutide damage a developing fetus if I become pregnant while taking it?
Animal studies show no fetal harm at therapeutic semaglutide doses, but human pregnancy data is limited, placing it in Pregnancy Category C. Current evidence does not support teratogenic (birth-defect-causing) risk, but stopping before conception is the evidence-based standard. If pregnancy occurs while taking semaglutide, inform your OB-GYN immediately—discontinuation is recommended, but brief exposure is not considered a medical emergency.
Does PlexusDx semaglutide cost more if I need to restart after pregnancy?
No. PlexusDx Semaglutide Injection starts at $149/month regardless of your treatment interruptions or restart schedule. Your dose may need to go up, but your price won't. You pay one flat monthly rate with no membership fees, and HSA/FSA funds are eligible—giving you complete cost predictability when resuming therapy postpartum.
Can semaglutide pass into breast milk if I restart after delivery?
Limited data exists on semaglutide transfer into breast milk, so most reproductive health guidelines recommend discussing timing with your OB-GYN. Many women choose to delay GLP-1 restart until breastfeeding is complete. PlexusDx supports whatever decision you and your medical team reach and can help you resume personalized therapy safely whenever that window opens.
How does the PlexusDx Precision Peptide Genetic Test help with pregnancy planning?
The Precision Peptide Genetic Test ($99 add-on) analyzes variants like GLP1R rs6923761 and FTO rs9939609—genetic markers that influence how your body responds to GLP-1 therapy and metabolic regulation. Understanding your unique peptide-pathway predispositions helps your medical team anticipate weight regain patterns during pregnancy and plan your postpartum GLP-1 restart more effectively, ensuring faster return to your goal weight when safe to resume.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Do GLP-1 Medications Do? Understanding Their Role in Weight Loss and Diabetes Management
Does BCBS Cover Wegovy or Ozempic for Weight Loss?